• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原代肝细胞的代谢激活能力扩展了胚胎干细胞测试作为替代实验动物测试的适用性。

Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing.

机构信息

Institute for Food Toxicology and Analytical Chemistry, University of Veterinary Medicine Hannover, Hannover, Germany.

出版信息

Reprod Toxicol. 2010 Aug;30(1):113-20. doi: 10.1016/j.reprotox.2010.01.009. Epub 2010 Feb 2.

DOI:10.1016/j.reprotox.2010.01.009
PMID:20132877
Abstract

The murine embryonic stem cell test (EST) represents a validated alternative method for in vivo embryotoxicity testing. In the present study, primary hepatocytes were combined with the EST by a preincubation approach to improve its predictivity on bioactivation caused teratogenicity. As substances the well-known proteratogens cyclophosphamide (CPA) and valpromide (VPD) were used. The embryotoxic potential of CPA was detected by a strong decrease of the resulting ID(50)-concentration (50% inhibition of ES cell differentiation) after incubation with murine hepatocytes. Interspecies variation in metabolism was detected by testing VPD. After incubation of VPD with murine hepatocytes no inhibition of ES cell differentiation was observed, since hardly any teratogenic VPD metabolites were formed. In contrast, with human hepatocytes a significant conversion of VPD into the teratogen valproic acid (VPA) was observed. In summary we developed a co-culture approach for embryotoxicity testing, whereby the test compounds were incubated with hepatocytes and the supernatant was added to the ES cell culture to obtain a dose dependency of the preincubated test substances.

摘要

鼠胚胎干细胞试验(EST)代表了一种经过验证的替代体内胚胎毒性测试的方法。在本研究中,通过预孵育方法将原代肝细胞与 EST 结合,以提高其对生物活化引起致畸性的预测能力。使用了两种众所周知的前致畸剂环磷酰胺(CPA)和丙戊酸(VPD)作为物质。用小鼠肝细胞孵育后,由于形成的 ID(50)浓度(ES 细胞分化的 50%抑制)明显降低,检测到 CPA 的胚胎毒性潜力。通过测试 VPD 检测到种间代谢的差异。用小鼠肝细胞孵育 VPD 后,未观察到 ES 细胞分化的抑制,因为几乎没有形成致畸性的 VPD 代谢物。相比之下,用人肝细胞观察到 VPD 显著转化为致畸剂丙戊酸(VPA)。总之,我们开发了一种用于胚胎毒性测试的共培养方法,其中将测试化合物与肝细胞孵育,并将上清液添加到 ES 细胞培养物中,以获得预孵育测试物质的剂量依赖性。

相似文献

1
Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing.原代肝细胞的代谢激活能力扩展了胚胎干细胞测试作为替代实验动物测试的适用性。
Reprod Toxicol. 2010 Aug;30(1):113-20. doi: 10.1016/j.reprotox.2010.01.009. Epub 2010 Feb 2.
2
An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.一种基于干扰小鼠胚胎干细胞向内皮细胞分化的体外胚胎毒性试验。II. 化合物测试。
Toxicol In Vitro. 2007 Dec;21(8):1631-40. doi: 10.1016/j.tiv.2007.06.014. Epub 2007 Jul 18.
3
Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test.在一项新修订的高通量胚胎干细胞试验中对化合物的胚胎毒性效力进行评估。
Toxicol Sci. 2008 Oct;105(2):342-50. doi: 10.1093/toxsci/kfn126. Epub 2008 Jun 30.
4
Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro.新型高通量胚胎干细胞试验结合新型分子标记物评估体外胚胎毒性化学物质的筛查
Toxicol Sci. 2011 Dec;124(2):460-71. doi: 10.1093/toxsci/kfr250. Epub 2011 Sep 29.
5
Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acid.使用两种经过验证的体外试验来评估麦考酚酸的胚胎毒性。
Arch Toxicol. 2010 Jan;84(1):37-43. doi: 10.1007/s00204-009-0476-1. Epub 2009 Oct 25.
6
ReProGlo: a new stem cell-based reporter assay aimed to predict embryotoxic potential of drugs and chemicals.ReProGlo:一种新型基于干细胞的报告基因检测方法,旨在预测药物和化学物质的胚胎毒性。
Reprod Toxicol. 2010 Aug;30(1):103-12. doi: 10.1016/j.reprotox.2009.12.002. Epub 2009 Dec 14.
7
Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.利用胚胎干细胞对甲基汞和铬进行胚胎毒性危害评估。
Toxicology. 2007 Dec 5;242(1-3):130-43. doi: 10.1016/j.tox.2007.09.022. Epub 2007 Sep 29.
8
Evaluation of developmental toxicant identification using gene expression profiling in embryonic stem cell differentiation cultures.利用胚胎干细胞分化培养中的基因表达谱评价发育毒物的识别。
Toxicol Sci. 2011 Jan;119(1):126-34. doi: 10.1093/toxsci/kfq291. Epub 2010 Oct 8.
9
Unexpected common mechanistic pathways for embryotoxicity of warfarin and lovastatin.华法林和洛伐他汀胚胎毒性的意外共同机制途径。
Reprod Toxicol. 2010 Aug;30(1):121-30. doi: 10.1016/j.reprotox.2010.05.006. Epub 2010 May 20.
10
Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity.胚胎干细胞试验中收缩性的自动化分析,一种评估胚胎毒性的新方法。
Toxicol In Vitro. 2008 Dec;22(8):1948-56. doi: 10.1016/j.tiv.2008.09.008. Epub 2008 Sep 19.

引用本文的文献

1
Toward better assessments of developmental toxicity using stem cell-based in vitro embryogenesis models.利用基于干细胞的体外胚胎发生模型,提高发育毒性评估的准确性。
Birth Defects Res. 2022 Oct 1;114(16):972-982. doi: 10.1002/bdr2.1984. Epub 2022 Jan 31.
2
Microfluidic Multitissue Platform for Advanced Embryotoxicity Testing In Vitro.用于体外高级胚胎毒性测试的微流控多组织平台
Adv Sci (Weinh). 2019 Apr 29;6(13):1900294. doi: 10.1002/advs.201900294. eCollection 2019 Jul 3.
3
Wind of change challenges toxicological regulators.变革之风挑战毒理学监管者。
Environ Health Perspect. 2012 Nov;120(11):1489-94. doi: 10.1289/ehp.1104782. Epub 2012 Aug 7.
4
Alternative models in developmental toxicology.发育毒理学中的替代模型。
Syst Biol Reprod Med. 2012 Feb;58(1):10-22. doi: 10.3109/19396368.2011.648302.
5
The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acid.胚胎干细胞测试作为评估结构相关致畸性的工具:以丙戊酸为例。
Toxicol Sci. 2011 Apr;120(2):360-70. doi: 10.1093/toxsci/kfr001. Epub 2011 Jan 11.